• Popular Recommendations

  • PEER
  • ultrasound
  • LLSA
  • sepsis
  • Home
    • /
  • ACEP Letters to Congress

ACEP Letters to Congress

Letter to Sec. Esper re USUHS from Frontline Physician Groups
ACEP Letter to SFC and WM on CY2021 PFS EM Codes -- 08042021.pdf
ACEP Letter of Support -- Dr Lorna Breen Health Care Provider Protection Act
Doc Caucus SMB Letter to WH
ACEP Letter of Support -- Essential Workforce Parity Act
ACEP Response to Ways and Means Rural and Underserved Communities Task Force
AMA Sign On Letter re H-1B IMG
ACEP Statement for the Record - Select Subcommittee on Coronavirus Crisis Hearing 7-1-20
ACEP Response HELP COVID-19 White Paper
ACEP Letter of Support--Coronavirus Health Care Workers Wellness Act
ACEP SUPPORT LETTER (HR 7059) 6-2-2020.pdf
Sign on letter in support of MAT Act FINAL to Congressional leaders
ACEP Support Letter (HR 2482) 05-18-20
ACEP Support Letter (Due Process) 04-16-20
CV4 Federation Letter 04-16-20
Sign-on Letter to House for MISSION:ZERO Funding 02.12.20
Sign-on Letter to Senate for MISSION:ZERO Funding 02.12.20
ACEP Letter for the Record - Caring for Aging Americans Hearing - November 14, 2019
ACEP Response to Data Request from Bipartisan Senate Workgroup
ACEP Letter of Support for H.R. 8/Universal Background Check Legislation
ACEP Response on Senate Price Transparency Draft Bill
Summary of ACEP Response on Senate Bipartisan Price Transparency Draft Bill
ACEP Letter on Conferencing of Senate and House Opioid Legislation 09.17.2018.pdf
ACEP Letter to Congress re: the Opioid Crisis Response Act - April 10, 2018
ACEP Letter to Congress re: the Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act of 2018 - May 4, 2018
ACEP Comments to Senate Committee on Health, Education, Labor, and Pensions re: S. 2680 - April 17, 2018
ACEP Letter of Support to Congress re: H.R. 3999 - October 12, 2017
ACEP Letter of Support to Congress re: H.R. 849 - October 3, 2017
ACEP Letter re: Individual Mandate Repeal Tax Reform - November 16, 2017
ACEP Comment Letter to FDA on Sublingual Formulations of Synthetic Fentanyl - Feb 2, 2017
ACEP Letter to Congress re: Opioids - November 16, 2017
ACEP Letter of Congratulations - January 25, 2018
ACEP Letter of Support to Congress re: Background Check Expansion - November 8, 2017
ACEP Letter of Support to Congress re: Fix NICS Act of 2017 - November 21, 2017
ACEP Letter of Support to Congress re: -- H.R. 3931 - October 19, 2017
ACEP Letter of Support to Congress re: S. 1905 - October 19, 2017
ACEP Letter to Congress re: Bipartisan Health Care Stabilization Act - October 19, 2017
ACEP Response to Senate Finance Committee re: Opioid Request - February 16, 2018
ACEP Response to the House Committee on Ways and Means re: Opioids - March 15, 2018
ACEP Response to Senator Cassidy re: Price Transparency and Accountability - March 23, 2018
ACEP Support Letter to Congress re: H.R. 6378 - July 18, 2018
AMA Sign On Letter to the National Council of State Boards of Nursing (NCSBN) re: APRN Compact - May 10, 2018
Group Letter re: Drug Shortages - June 15, 2018
Sign On Letter to Congress re: CDC Research Funding - April 27, 2018
Group Letter to Congress re: Sickle Cell Disease Legislation S. 2465 - July 18, 2018
Guthrie-Doyle Letter Re: Drug Shortages - June 18, 2018
Group Letter to Committee on Energy and Commerce re: Medicare Access and CHIP Reauthorization Act MACRA Letter - October 2, 2017
Turner-Moulton Letter to Secretary Mattis re: Opioids - December 8, 2017
LIVE CHAT
[ Feedback → ]